Erythropoiesis: Components and Mechanisms (R01)Funding Number: PA-09-255
Funding Type: PA
Release Date: August 14, 2009
Expiration Date: September 8, 2012
Web Site: http://grants.nih.gov/grants/guide/pa-files/PA-09-255.html
Purpose. This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) the National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, encourages investigator-initiated R01 applications that propose hypothesis-driven research using erythroid cells. The aim of this program is to support research efforts towards a complete description of the molecular and cellular components of erythropoiesis and how these components contribute to erythropoiesis. Components include genes that are expressed (transcriptome) in erythroid cells, either during development or during differentiation, and the proteins (proteome) that are translated in erythroid cells, especially with post-translational modifications or subcellular localizations that are unique to erythroid cells. A long range goal of this program is to generate a concise description of erythropoiesis that unifies genetics, molecular processes and cytokine determinants in the erythroid lineages so that new therapeutics may be developed to measure and combat anemia. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.